| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/09/2003 | EP1300418A1 Gene regulation by oligopeptides |
| 04/09/2003 | EP1300417A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/09/2003 | EP1300157A1 Attenuated mutant newcastle disease virus strains for in ovo vaccination, method for preparing and their use |
| 04/09/2003 | EP1300156A2 Otitis media vaccine |
| 04/09/2003 | EP1299728A2 Receptor assay for detecting an effect test compounds have on a particular membrane receptor |
| 04/09/2003 | EP1299725A2 Herpes zinc finger motifs |
| 04/09/2003 | EP1299724A2 Synthetic peptide for neurological disorders |
| 04/09/2003 | EP1299562A1 Gene expression in biological conditions |
| 04/09/2003 | EP1299561A2 A method for producing multifunctional lysyl hydroxylases with glycosyltransferase activity |
| 04/09/2003 | EP1299556A2 Host cells containing multiple integrating vectors |
| 04/09/2003 | EP1299554A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 04/09/2003 | EP1299547A1 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 04/09/2003 | EP1299544A2 Fimh adhesin proteins and methods of use |
| 04/09/2003 | EP1299543A2 Hypersensitive response eliciting domains of bacterial harpins and use thereof |
| 04/09/2003 | EP1299541A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 04/09/2003 | EP1299540A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 04/09/2003 | EP1299539A1 Myocardium-specific promoter |
| 04/09/2003 | EP1299538A2 Secreted proteins |
| 04/09/2003 | EP1299537A1 Compounds targeted to cellular locations |
| 04/09/2003 | EP1299536A1 Novel alpha-catenin expressed in heart and testis |
| 04/09/2003 | EP1299535A2 Peptide extended glycosylated polypeptides |
| 04/09/2003 | EP1299534A2 Grf2-binding proteins and applications thereof |
| 04/09/2003 | EP1299530A2 Novel compounds |
| 04/09/2003 | EP1299529A2 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 04/09/2003 | EP1299528A1 Human olfactory receptors and genes encoding same |
| 04/09/2003 | EP1299526A1 Method for the production of hydroxylated collagen-like compounds |
| 04/09/2003 | EP1299522A2 Alteration of cell membrane |
| 04/09/2003 | EP1299457A1 Mammalion haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof |
| 04/09/2003 | EP1299418A1 Insulin derivatives and synthesis thereof |
| 04/09/2003 | EP1299417A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/09/2003 | EP1299416A2 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 04/09/2003 | EP1299415A1 Chemokine receptor modulators, production and use |
| 04/09/2003 | EP1299414A2 Fluorescent proteins |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299411A1 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases |
| 04/09/2003 | EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 04/09/2003 | EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function |
| 04/09/2003 | EP1299327A2 Phosphorylated polypeptides and uses related thereto |
| 04/09/2003 | EP1299127A2 The nip3 family of proteins |
| 04/09/2003 | EP1299116A2 Helicobacter pylori with modified lipopolysaccharide biosynthesis |
| 04/09/2003 | EP1299115A2 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 04/09/2003 | EP1299094A2 Selective androgen receptor modulators and methods for their identification, design and use |
| 04/09/2003 | EP1218392A4 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 04/09/2003 | EP1083922B1 Composition and method for treatment of pseudomonas aeruginosa |
| 04/09/2003 | EP1049479A4 Analgesic from snake venom |
| 04/09/2003 | EP1029034A4 Signal peptide containing proteins and uses therefor |
| 04/09/2003 | EP0998494B1 Pompilid wasp-derived neuropeptides |
| 04/09/2003 | EP0954524B1 Process for purifying apolipoproteins |
| 04/09/2003 | EP0882064B1 Fsh and lh separation and purification process |
| 04/09/2003 | EP0840748B1 Transforming growth factor beta crystals |
| 04/09/2003 | EP0806477B1 Use of a recombinant dna comprising dna coding for smooth muscle-type myosin heavy-chain sm1 isoform protein in the manufacture of a medicament |
| 04/09/2003 | EP0804552B1 Redirection of cellular immunity by receptor chimeras |
| 04/09/2003 | EP0784685B1 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 04/09/2003 | EP0779933B1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 04/09/2003 | EP0758384B1 Leishmania major protein, nucleic acid coding therefor, and uses thereof |
| 04/09/2003 | EP0725824B1 Immunodominant human t-cell epitopes of hepatitis c virus |
| 04/09/2003 | EP0723455B1 Method of inhibiting phagocytosis |
| 04/09/2003 | EP0722462B1 Dna encoding prostaglandin receptor ip |
| 04/09/2003 | EP0708834B1 Formation of and methods for the production of large (bacillus thuringiensis) crystals with increased pesticidal activity |
| 04/09/2003 | EP0708831B1 Cell-density enhanced protein tyrosine phosphatases |
| 04/09/2003 | EP0675956B1 New protein from urine named component b |
| 04/09/2003 | EP0482053B1 Methode for inhibiting ethylene production in plants |
| 04/09/2003 | CN1409767A Recombinant sendai virus vector for introducing exogenous gene to airway epithelia |
| 04/09/2003 | CN1409765A Prevention of myocarditis, abortion and intrauterine infection associated with procine circovirus 2 |
| 04/09/2003 | CN1409764A Pseudomonas aeruginosa antigens |
| 04/09/2003 | CN1409763A Photosensitivity gene of plant and utilization thereof |
| 04/09/2003 | CN1409755A Production of peptides by fedbatch cultivation of microoganism |
| 04/09/2003 | CN1409726A Type I cytokine receptor TCCR |
| 04/09/2003 | CN1409725A Peptide minics of conserved gonococcal epitopes and methods and compositions using them |
| 04/09/2003 | CN1409114A REG sample protein |
| 04/09/2003 | CN1408881A Synaptic knob association membrane protein 25 and its use |
| 04/09/2003 | CN1408871A Cotton agglutinant protein coding sequence and its use |
| 04/09/2003 | CN1408870A Human transcription factor, its coding sequence preparation and use |
| 04/09/2003 | CN1408868A Gene NSPL1 with expression difference in human normal neuroglia cell and neuroglia cell tumor |
| 04/09/2003 | CN1408867A Gene NECL2 with expression difference in human normal neuroglia cell and neuroglia cell tumor |
| 04/09/2003 | CN1408866A Human fertilization promotion peptide receptor TCP11 and its coding sequence and preparation and use |
| 04/09/2003 | CN1408861A Recombination human platelet producing factor cDNA sequence and its use |
| 04/09/2003 | CN1408860A New human primary azoospermatism relative zinc finger protein and coding sequence and preparation and use |
| 04/09/2003 | CN1408858A Vermis kinase and its use in therapy of thrombus diseases |
| 04/09/2003 | CN1408849A Process for preparing recombination human glicentin-1(7-37) |
| 04/09/2003 | CN1408727A Method for efficiently expressing recombinant human interleukin 12 in eukaryotic cell |
| 04/09/2003 | CN1408726A Preparation of non-mitogenic recombination acid fibrolast growth factor (aFGF) mutant |
| 04/09/2003 | CN1408725A Process for preparing human blood platelet glucoprotein GPIb alpha and its special primer |
| 04/09/2003 | CN1408724A Novel testicular function relative protein and its use |
| 04/09/2003 | CN1408723A First hypervariable region antigen of hepatitis C and fusion antigen |
| 04/09/2003 | CN1105187C Protocadherin proteins and their use |
| 04/09/2003 | CN1105186C Gene imparting flocculability to yeast and gene product |
| 04/09/2003 | CN1104907C Vibrio cholerae 01 (CVD111) and Non-01 (CVD112 and CVD112 RM) serogroup vaccine strain and methods of making same |
| 04/08/2003 | US6545202 Transgenic plant transformed with a translationally controlled tumor protein (TCTP) gene |
| 04/08/2003 | US6545201 Isolated nucleic acids; inserted into plant; transgenic |
| 04/08/2003 | US6545198 Transgenically produced prolactin |
| 04/08/2003 | US6545142 Primers; nucleotide sequence |
| 04/08/2003 | US6545141 Brain-specific adapter molecule, gene thereof, and antibody thereto |
| 04/08/2003 | US6545140 DNA encoding an avian beta-defensin and uses thereof |
| 04/08/2003 | US6545139 Genetic engineering; anticancer agents |
| 04/08/2003 | US6545137 Autoimmune diseases; antiinflammatory agents; viricides; antidiabetic agents; binding to low density lipoproteins |
| 04/08/2003 | US6545132 Isolation, detection of proteins |
| 04/08/2003 | US6545131 Tissue specific prodrug |
| 04/08/2003 | US6545129 Human selenoprotein |
| 04/08/2003 | US6545128 Anti-bax inhibitor protein antibodies |